Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.

Neumiller, Joshua J; Wood, Lindy; Campbell, R Keith

Neumiller, Joshua J; Wood, Lindy; Campbell, R Keith.

Affiliation

Neumiller JJ; Department of Pharmacotherapy, Washington State University, and Elder Services, Spokane, Washington 99217, USA. jneumiller@wsu.edu

Pharmacotherapy ; 30(5): 463-84, 2010 May.

Article in En | MEDLINE | ID: mdl-20411998

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors/therapeutic use; Hypoglycemic Agents/therapeutic use; Animals; Body Weight/drug effects; Diabetes Mellitus, Type 2/physiopathology; Dipeptidyl Peptidase 4; Drug Interactions; Enzyme Inhibitors/adverse effects; Enzyme Inhibitors/pharmacokinetics; Enzyme Inhibitors/pharmacology; Humans; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/pharmacokinetics; Hypoglycemic Agents/pharmacology; Incretins/physiology; Insulin-Secreting Cells/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Enzyme Inhibitors / Dipeptidyl-Peptidase IV Inhibitors / Hypoglycemic Agents Limits: Animals / Humans Language: En Journal: Pharmacotherapy Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google